Page last updated: 2024-08-21

thiazoles and Immune System Diseases

thiazoles has been researched along with Immune System Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Artym, J; Jankowski, S; Jędrzejczak, K; Katarzyńska, J; Kochanowska, I; Lisowski, M; Marcinek, A; Piotrowski, Ł; Wieczorek, R; Zabrocki, J; Zimecki, M1
Cohen, JA; McGinley, MP1
Appell, KC; Beasley, JR; Carroll, CD; Lin, T; Rokosz, LL; Webb, ML; Zhao, J1
Fujita, H; Kadowaki, N; Kamihira, S; Kitawaki, T; Maeda, T; Sato, T; Takaori-Kondo, A1
Ault, KA; Carmody, MB; Hillman, RS; Mitchell, J; Rinder, HM; Vary, CP1

Reviews

2 review(s) available for thiazoles and Immune System Diseases

ArticleYear
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions.
    Lancet (London, England), 2021, 09-25, Volume: 398, Issue:10306

    Topics: Animals; Azetidines; Benzyl Compounds; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immune System Diseases; Indans; Multiple Sclerosis; Nervous System Diseases; Oxadiazoles; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Thiazoles

2021
Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges.
    Expert opinion on therapeutic targets, 2008, Volume: 12, Issue:7

    Topics: Animals; Benzamides; Chronic Disease; Clinical Trials as Topic; Dasatinib; Humans; Imatinib Mesylate; Immune System Diseases; Inflammation; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles

2008

Other Studies

3 other study(ies) available for thiazoles and Immune System Diseases

ArticleYear
4-Methylpseudoproline analogues of cyclolinopeptide A: Synthesis, structural analysis and evaluation of their suppressive effects in selected immunological assays.
    Peptides, 2020, Volume: 132

    Topics: Amino Acid Sequence; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Circular Dichroism; Female; Humans; Immune System Diseases; Immunosuppressive Agents; Lymphocytes; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred CBA; Peptides, Cyclic; Proline; Sheep; Spleen; Structure-Activity Relationship; Thiazoles

2020
The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA.
    European journal of immunology, 2013, Volume: 43, Issue:1

    Topics: Cells, Cultured; Cytokines; Dasatinib; Dendritic Cells; Endosomes; Humans; Immune System Diseases; Immunosuppressive Agents; Inflammation Mediators; Molecular Targeted Therapy; Oligodeoxyribonucleotides; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles; Toll-Like Receptor 7; Toll-Like Receptor 9

2013
The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis.
    American journal of clinical pathology, 1992, Volume: 98, Issue:6

    Topics: Animals; Benzothiazoles; Blood Platelets; Fluorescent Dyes; Hematopoiesis; Humans; Immune System Diseases; Immunoglobulins; Mice; Mice, Inbred BALB C; Quinolines; Reference Values; Ribonucleases; RNA; Sensitivity and Specificity; Thiazoles; Thrombocytopenia

1992